TrialPediatric blood & cancer2023

Feasibility and preliminary efficacy of the Balance Program to reduce pain-related disability in pediatric sickle cell disease.

Megan E Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.